Cargando…

Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma

Oral tongue squamous cell carcinoma (OTSCC) is an aggressive cancer associated with poor prognosis. Methods for determining the aggressiveness of OTSCC from analysis of the primary tumour specimen are thus highly desirable. We investigated whether genomic instability and proliferative activity (by m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wangsa, D, Ryott, M, Åvall-Lundqvist, E, Petersson, F, Elmberger, G, Luo, J, Ried, T, Auer, G, Munck-Wikland, E
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2008
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2567086/ https://www.ncbi.nlm.nih.gov/pubmed/18766188 http://dx.doi.org/10.1038/sj.bjc.6604633

Ejemplares similares

Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade
por: Burger, M, et al.
Publicado: (2007)

HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ
por: Rakovitch, E, et al.
Publicado: (2012)

A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms
por: Khan, M S, et al.
Publicado: (2013)

Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer
por: Ali, H R, et al.
Publicado: (2012)

Expression of DNA damage response proteins and complete remission after radiotherapy of stage IB–IIA of cervical cancer
por: Beskow, C, et al.
Publicado: (2006)

Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53
por: Millar, E K A, et al.
Publicado: (2011)

Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas
por: Torres-Rendon, A, et al.
Publicado: (2009)

KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer–a targeted molecular approach
por: Green, William JF, et al.
Publicado: (2016)

Human papillomavirus, p16(INK4A), and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina
por: Hellman, K, et al.
Publicado: (2014)

Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer
por: Burcombe, R J, et al.
Publicado: (2005)

The prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma
por: Klimowicz, A C, et al.
Publicado: (2013)

Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer
por: Mohammed, Z M A, et al.
Publicado: (2012)

Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma
por: Schrader, C, et al.
Publicado: (2005)

Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role
por: Warth, A, et al.
Publicado: (2014)

Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study
por: Uijterwaal, M H, et al.
Publicado: (2014)

Rapid nodal staging of head and neck cancer surgical specimens with flow cytometric analysis
por: Häyry, Valtteri, et al.
Publicado: (2018)

High Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction
por: Kikuchi, M, et al.
Publicado: (2009)

Ki-67 and CK-19 are predictors of locoregional recurrence in papillary thyroid carcinoma
por: Viana, Aline de Oliveira Ribeiro, et al.
Publicado: (2020)

Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas
por: Andersson, S, et al.
Publicado: (2006)

Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue
por: Kauppila, J H, et al.
Publicado: (2013)

Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients
por: Tonini, G, et al.
Publicado: (2005)

High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer
por: Böckelman, C, et al.
Publicado: (2011)

Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups
por: Sundquist, Elias, et al.
Publicado: (2017)

Aberrant expression of RAB1A in human tongue cancer
por: Shimada, K, et al.
Publicado: (2005)

Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue
por: Häyry, V, et al.
Publicado: (2010)

Downregulation of miRNA-424: a sign of field cancerisation in clinically normal tongue adjacent to squamous cell carcinoma
por: Boldrup, L, et al.
Publicado: (2015)

Expression of p16 in squamous cell carcinoma of the mobile tongue is independent of HPV infection despite presence of the HPV-receptor syndecan-1
por: Sgaramella, N, et al.
Publicado: (2015)

Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer
por: Snoeren, N, et al.
Publicado: (2013)

Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis
por: Almangush, Alhadi, et al.
Publicado: (2017)

The Ki67 index a prognostic marker in medullary thyroid carcinoma
por: Tisell, L E, et al.
Publicado: (2003)

Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer
por: Toyoda, M, et al.
Publicado: (2014)

Genomic instability and proliferative activity as risk factors for distant metastases in breast cancer
por: Li, L, et al.
Publicado: (2008)

Akt/Ezrin Tyr353/NF-κB pathway regulates EGF-induced EMT and metastasis in tongue squamous cell carcinoma
por: Wang, Y, et al.
Publicado: (2014)

BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers
por: Lee, Y-K, et al.
Publicado: (2009)

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence
por: den Uil, Sjoerd H, et al.
Publicado: (2016)

Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer
por: Zeestraten, E C M, et al.
Publicado: (2012)

Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma
por: Tabori, U, et al.
Publicado: (2008)

Chromatin changes predict recurrence after radical prostatectomy
por: Hveem, Tarjei S, et al.
Publicado: (2016)

The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma
por: Åström, Pirjo, et al.
Publicado: (2017)

The utility of molecular diagnostics to predict recurrence of head and neck carcinoma
por: Pena Murillo, C, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_nkfk5hm6et8gmbvpnis8q9ofdp